The topic of high prescription drug prices is now the dominant policy issue on Capitol Hill. The new Congress has held a half-dozen hearings on the topic. But one issue that is at the heart of high prices has attracted little attention: the role of biologic drugs in rising drug costs. In 2017, according to data from the IQVIA Institute,